Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine

HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine

US Patent 7115584 · Granted Oct 3, 2006

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Progesterone analogs and uses related thereto2025
Substituted nucleosides and nucleotides for treating viral infections2025
GluN2B-subunit selective antagonists of the N-methyl-D-aspartate receptors with 2025
Progesterone phosphate analogs and uses related thereto2025
Abelson non-tyrosine kinase compounds for the treatment of neurodegenerative dis2025
GluN2C/D subunit selective antagonists of the N-methyl-D-aspartate receptor2025
Antiviral JAK inhibitors useful in treating or preventing retroviral and other v2025
Lipid disulfide prodrugs and uses related thereto2025
Modulators of orphan nuclear receptors for NASH and other metabolic disorders2025
Pyrazoline dihydroquinolones, pharmaceutical compositions, and uses2025
Pan-tropic entry inhibitors2025
Peptidomimetics for the treatment of coronavirus and picorna virus infections2025